| Investigator |
Title |
Sponsor |
ID |
Dates |
Amount |
| Heidi Mills Andersen, MD |
St. Baldrick's Scholar Career Development Award |
St. Baldrick's Foundation |
580634 |
7/1/2018 - 6/30/2019 |
$110,000 |
| David I Bernstein, MD |
Vaccine and Treatment Evaluation Unites (VTEU) - Flu |
National Institutes of Health (NIH) |
14-0112.B1C1D1.0029 |
9/22/2016 - 12/31/2019 |
$195,027 |
| David I Bernstein, MD |
Mouse and Guinea Pig Models for Cytomegalovirus and Herpes Simplex Viruses |
National Institutes of Health (NIH) |
HHSN27200003 |
11/1/2018 - 10/30/2019 |
$737,729 |
| Steven Black, MD |
CISA Clinical Vaccine Safety Evaluation - Contributing Consult |
National Institutes of Health (NIH) |
200-2012-53661 |
9/29/2018 - 9/28/2019 |
$42,008 |
| Lara Danziger-Isakov, MD-MPH |
B-Cell Targeted Induction to Improve Outcomes in Pediatric Lung Transplantation |
Washington University (National Institutes of Health (NIH)) |
WU-18-115 |
3/1/2017 - 8/31/2019 |
$155,987 |
| Lara Danziger-Isakov, MD-MPH |
Outcomes of Human Adenovirus (HAdV) Infection and Disease in Pediatric Allogeneic Stem Cell Transplant Recipients: A Prospective Multicenter Observational Cohort |
Children's Hospital of Philadelphia (National Institutes of Health (NIH)) |
HHSN272201600014C |
8/22/2018 - 8/21/2021 |
$264,286 |
| Lara Danziger-Isakov, MD-MPH |
Phase II Multi-Center, Prospective, Randomized, Double-Blind Study of Nitazoxanide in Acute and Chronic Norovirus in Hematpoietic Stem Cell and Solid Organ Transplant Recipients |
Northwestern University Medical School (National Institutes of Health (NIH)) |
SP0033779 60044358 |
7/1/2016 - 6/30/2021 |
$392,393 |
| Lara Danziger-Isakov, MD-MPH |
Comparison of High vs. Standard Dose Flu Vaccine in Pediatric Stem Cell Transplant Recipients |
Vanderbilt University (National Institutes of Health (NIH)) |
VUMC59100 |
8/1/2018 - 7/31/2019 |
$102,960 |
| Robert W Frenck, MD |
RTOP FY.2019.A1B1C1D1.0103 |
National Institutes of Health (NIH) |
FY.2019.A1B1C1D1.010 |
7/12/2018 - 7/11/2019 |
$395,323 |
| Robert W Frenck, MD |
RTOP FY.2019.A1B1C1D1.0103 |
National Institutes of Health (NIH) |
FY.2019.A1B1C1D1.010 |
4/5/2019 - 10/30/2021 |
$2,699,525 |
| Robert W Frenck, MD |
IMPAACT PSTO - 018.09 |
Johns Hopkins School of Medicine (National Institutes of Health (NIH)) |
PTCL02 |
1/1/2018 - 11/30/2018 |
$39,750 |
| Robert W Frenck, MD |
18-0010.B1C1.0120 |
National Institutes of Health (NIH) |
18-0010.B1C1.0120 |
4/15/2019 - 9/15/2019 |
$74,436 |
| Margaret K Hostetter, MD |
Pediatric Scientist Development Program (K12) 2017-2022 |
National Institutes of Health (NIH) |
K12HD000850 |
7/1/2018 - 6/30/2019 |
$1,417,611 |
| Xi Jason Jiang, PHD |
HBGA receptors in host cell entry and infection of norovirus |
Purdue University (National Institutes of Health (NIH)) |
4102-65270 |
12/1/2018 - 11/30/2019 |
$259,923 |
| Grant Paulsen, MD |
18-0011.B1C1.0116 |
National Institutes of Health (NIH) |
HHSN27220130000161 |
10/15/2018 - 7/31/2021 |
$1,082,877 |
| Joseph Edward Qualls, PHD |
L-citrulline and anti-tuberculosis host defense |
National Institutes of Health (NIH) |
R01AI116668 |
7/1/2018 - 6/30/2019 |
$390,000 |
| Nancy M Sawtell, PHD |
Forward genetic prediction and testing of virulence loci in herpes simplex virus |
Pennsylvania State University (National Institutes of Health (NIH)) |
R01AI132692 |
2/23/2018 - 1/31/2019 |
$54,370 |
| Elizabeth Schlaudecker, MD |
Safety of Adjuvanted versus High-Dose Inactivated Influenza Vaccines in Older Adults (Contributing) |
Boston Medical Center (Ctr for Disease Control and Prevention) |
200-2012-53709 |
9/29/2017 - 9/28/2019 |
$122,191 |
| Elizabeth Schlaudecker, MD |
Safety of Recombinant Influenza Vaccine (Flublok) in Pregnant Women (Contributing) |
National Institutes of Health (NIH) |
200-2012-53661-0010 |
9/15/2018 - 9/14/2019 |
$612,766 |
| Paul W Spearman, MD |
Vaccine and Treatment Evaluation Units (VTEU) Protocol D |
National Institutes of Health (NIH) |
HHSN272201300016I |
8/28/2017 - 6/30/2018 |
$94,484 |
| Paul W Spearman, MD |
HIV-1 Particle Capture and VCC Formation in Microglia |
National Institutes of Health (NIH) |
R21NS107031 |
4/1/2019 - 3/31/2020 |
$198,750 |
| Paul W Spearman, MD |
Role of Vpu, Tetherin, and Siglec-1 in HIV-1 Replication |
National Institutes of Health (NIH) |
R01GM132068 |
9/15/2018 - 8/31/2019 |
$423,814 |
| Paul W Spearman, MD |
Viral and Cellular Determinants of HIV-1 Assembly - Resu |
National Institutes of Health (NIH) |
R01GM111027 |
2/1/2019 - 1/31/2020 |
$357,750 |
| Mary Allen Staat, MD |
Enhanced Surveillance for New Vaccine Preventable Diseases |
National Institutes of Health (NIH) |
U01IP001059 |
9/1/2018 - 8/31/2019 |
$2,426,950 |
| Mary Allen Staat, MD |
Apnea in Hospitalized Preterm Infants Following the Administration of Routine Childhood Vaccines (Contributing) |
National Institutes of Health (NIH) |
200-2012-53661/0007 |
9/15/2018 - 9/14/2019 |
$229,674 |
| Mary Allen Staat, MD |
Quadrivalent Live Attenuated Influenza Vaccine (LAIV4) in Children with Varying Levels of Severity and Control (Contributing) |
National Institutes of Health (NIH) |
00HCVLDE-2018-24194 |
4/1/2018 - 9/29/2019 |
$117,248 |
| Mary Allen Staat, MD |
Quadrivalent Live Attenuated Influenza Vaccine (LAIV4) in Children with Varying Levels of Severity and Control (Contributing) |
National Institutes of Health (NIH) |
00HCVLDE-2018-24194 |
4/1/2018 - 9/29/2019 |
$60,838 |
| Mary Allen Staat, MD |
Impact of the Initial Influenza Exposure on the Quality, Magnitude, Breadth, Potency and Durability of Influenza Immunity |
National Institutes of Health (NIH) |
U01AI144673 |
5/15/2019 - 4/30/2020 |
$4,655,925 |
| Sing Sing Way, MD-PHD |
Maternal Regulatory T cell antigen-specificity |
National Institutes of Health (NIH) |
R01AI120202 |
11/1/2018 - 10/31/2019 |
$390,000 |
| Sing Sing Way, MD-PHD |
Immunological identity redefined by genetically foreign |
National Institutes of Health (NIH) |
DP1AI131080 |
8/1/2018 - 7/31/2019 |
$1,092,000 |
| Sing Sing Way, MD-PHD |
HHMI Faculty Scholar Award |
Howard Hughes Medical Institute |
55108587 |
11/1/2018 - 10/31/2019 |
$120,000 |
| Sing Sing Way, MD-PHD |
Functional immune tolerance to non-inherited maternal antigen |
National Institutes of Health (NIH) |
R01AI124657 |
2/1/2019 - 1/31/2020 |
$390,000 |
| Current Year Direct |
$19,706,595 |
